SCHEMBL6093929

SCHEMBL6093929

O=C([O-])C1CCN(Cc2ccc(Cl)cc2)CC1.[Na+]

nearest known ligand 0.60

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.54
DRD4 P21917 1/20 0.54
DRD3 P35462 1/20 0.54
TEAD1 P28347 1/20 0.53
GAA P10253 1/20 0.52
SIGMAR1 Q99720 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
ALDH1A1 P00352 3/20 0.52
KDM4E B2RXH2 2/20 0.52
MAPT P10636 1/20 0.52
HTT P42858 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
CYP2D6 P10635 1/20 0.52
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2314934 0.86 MEN1 (0.64) DRD2DRD4DRD3SIGMAR1MEN1
SCHEMBL22265838 0.84 ATM (0.58) DRD4GAASIGMAR1HDAC8ALDH1A1
SCHEMBL2073212 0.84 DRD2 (0.60) DRD2DRD4DRD3TEAD1GAA
Lithium Ion SCHEMBL22470219 0.83 MEN1 (0.64) DRD2DRD4DRD3SIGMAR1MEN1
SCHEMBL21820693 0.83 TEAD1 (0.58) DRD2DRD4DRD3TEAD1GAA
SCHEMBL5368002 0.83 GAA (0.69) DRD2DRD4DRD3TEAD1GAA
Lithium Ion SCHEMBL22470222 0.81 KCNH2 (0.56) MEN1KMT2A
SCHEMBL16695229 0.78 S1PR5 (0.65) GAA
SCHEMBL6093231 0.77 KDM4E (0.77) ALDH1A1KDM4EMAPTKMT2A
SCHEMBL9561721 0.77 SIGMAR1 (0.68) DRD2DRD4DRD3SIGMAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7125895-B1 Cyclic amine derivatives and their uses BRISTOL-MYERS SQUIBB PHARMA RESEARCH LABS, INC. (US) 2006-10-24 US disclosed
EP-1181278-B1 CYCLIC AMINE DERIVATIVES AND THEIR USES BRISTOL MYERS SQUIBB PHARMA RE (US) 2004-09-29 EP disclosed
EP-1181278-A1 CYCLIC AMINE DERIVATIVES AND THEIR USES Combichem, Inc. (US) 2002-02-27 EP disclosed
WO-2000069820-A1 CYCLIC AMINE DERIVATIVES AND THEIR USES COMBICHEM, INC. (US) 2000-11-23 WO disclosed